The USD/JPY appears to be headed for 102.00

Downside breakout from short-term bullish trendline.

FOREX 9

The US Dollar was bearish against all of its major pairs on Wednesday. On the US economic data front, Wholesale Inventories fell 0.1% on month in the November preliminary reading (+0.6% expected), compared to a revised +1.2% in the October final reading. Market News International's Chicago Business Barometer unexpectedly rose to 59.5 on month in December (56.3 expected), from 58.2 in November. Finally, Pending Home Sales declined 2.6% on month in November (0% expected), compared to a revised -0.9% in October.

On Thursday, Initial Jobless Claims for the week ending December 26th are expected to rise to 833K, from 803K in the previous week. Finally, Continuing Claims for the week ending December 19th are expected to increase to 5,390K, from 5,337K in the week before.     

The Euro was bearish against most of its major pairs with the exception of the CHF and USD. In the U.K., the Nationwide Building Society has posted its house price index for December +0.8% (vs +0.4% over one month expected). 

The Australian dollar was bullish against all of its major pairs.


Technically speaking, on a daily chart, the USD/JPY currency pair just broke out to the downside of a short-term bullish trendline that began to form on December 17th. The simple moving averages (SMAs) are arranged in a bearish manner, as the 20-day SMA is below the 50-day SMA. If the pair continues to fall then its next support levels would be 102.88 and 102.00. If the pair rallies traders should look for resistance at 103.90. If price gets above 103.90, then the pair could advance towards 104.58 before it hits resistance.     



Source: GAIN Capital, TradingView

More from Forex

Disclaimer

This report is intended for general circulation only. It should not be construed as a recommendation, or an offer (or solicitation of an offer) to buy or sell any financial products. The information provided does not take into account your specific investment objectives, financial situation or particular needs. Before you act on any recommendation that may be contained in this report, independent advice ought to be sought from a financial adviser regarding the suitability of the investment product, taking into account your specific investment objectives, financial situation or particular needs.

GAIN Capital Singapore Pte. Ltd., may distribute reports produced by its respective foreign entities or affiliates within the GAIN Capital group of companies or third parties pursuant to an arrangement under Regulation 32C of the Financial Advisers Regulations. Where the report is distributed to a person in Singapore who is not an accredited investor, expert investor or an institutional investor (as defined in the Securities Futures Act), GAIN Capital Singapore Pte. Ltd. accepts legal responsibility to such persons for the contents of the report only to the extent required by law. Singapore recipients should contact GAIN Capital Singapore Pte. Ltd. at 6826 9988 for matters arising from, or in connection with the report.

In the case of all other recipients of this report, to the extent permitted by applicable laws and regulations neither GAIN Capital Singapore Pte. Ltd. nor its associated companies will be responsible or liable for any loss or damage incurred arising out of, or in connection with, any use of the information contained in this report and all such liability is hereby expressly disclaimed. No representation or warranty is made, express or implied, that the content of this report is complete or accurate.

GAIN Capital Singapore Pte. Ltd. is not under any obligation to update this report.

Trading CFDs and FX on margin carries a high level of risk that may not be suitable for some investors. Consider your investment objectives, level of experience, financial resources, risk appetite and other relevant circumstances carefully. The possibility exists that you could lose some or all of your investments, including your initial deposits. If in doubt, please seek independent expert advice. Visit cityindex.com.sg for the complete Risk Disclosure Statement.